source
- Celcuity's breast cancer win; Odyssey plans $205M IPOCelcuity’s breast cancer drug wins again: The company said two regimens with its experimental drug gedatolisib succeeded in PIK3CA mutant patients as part of its Phase 3 trial. Last year ...Endpoints · 3mo ago↗ source
- STAT+: Pump the brakes on AI, buddy; and deposition deadlockIt's tough to write nuanced headlines, but a new study on AI in emergency rooms is getting way overhyped.STAT · 3mo ago↗ source
- Biotech has a new startup model: Small team, big check and Chinese assetsA new flavor of company is shaking up how biotechs are built. Instead of launching with eye-popping early-stage science or a new platform, there's a surge of startups with small teams, large checks…Endpoints